Stock GEHC GE HEALTHCARE TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
78.02 USD -0.70% Intraday chart for GE HealthCare Technologies Inc. -2.29% +0.91%
May. 30 GE HealthCare, Tampa General Hospital Expand Collaboration in Imaging, Ultrasound Technology MT
May. 30 GE Healthcare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida CI

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 26,546 35,199 35,613 - -
Enterprise Value (EV) 1 33,350 42,137 40,772 38,777 36,424
P/E ratio 14 x 25.4 x 19.2 x 16.9 x 15.1 x
Yield - - 0.12% 0.22% 0.27%
Capitalization / Revenue 1.45 x 1.8 x 1.77 x 1.68 x 1.6 x
EV / Revenue 1.82 x 2.16 x 2.02 x 1.83 x 1.63 x
EV / EBITDA 10.6 x 11.8 x 11.1 x 9.77 x 8.56 x
EV / FCF - 24.6 x 22.2 x 23.8 x 11.7 x
FCF Yield - 4.07% 4.5% 4.19% 8.52%
Price to Book - 4.94 x 4.21 x 3.33 x 2.78 x
Nbr of stocks (in thousands) 454,710 455,243 456,465 - -
Reference price 2 58.38 77.32 78.00 78.00 78.00
Announcement Date 1/30/23 2/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 18,341 19,552 20,165 21,160 22,286
EBITDA 1 3,155 3,566 3,678 3,970 4,257
EBIT 1 2,522 2,956 3,163 3,446 3,775
Operating Margin 13.75% 15.12% 15.69% 16.28% 16.94%
Earnings before Tax (EBT) 1 2,512 2,361 2,551 2,889 3,223
Net income 1 1,916 1,568 1,858 2,119 2,360
Net margin 10.45% 8.02% 9.21% 10.01% 10.59%
EPS 2 4.180 3.040 4.059 4.605 5.175
Free Cash Flow 1 - 1,714 1,837 1,626 3,103
FCF margin - 8.77% 9.11% 7.69% 13.92%
FCF Conversion (EBITDA) - 48.07% 49.94% 40.97% 72.89%
FCF Conversion (Net income) - 109.31% 98.86% 76.76% 131.51%
Dividend per Share 2 - - 0.0933 0.1697 0.2142
Announcement Date 1/30/23 2/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 4,576 4,938 4,707 4,817 4,822 5,206 4,650 4,883 5,067 5,542 4,911 5,150
EBITDA 1 - - - - 808 981 749 893.6 962.3 1,096 910.4 -
EBIT 1 - 777 664 711 744 837 681 738.5 807.1 945 751.6 807.3
Operating Margin - 15.74% 14.11% 14.76% 15.43% 16.08% 14.65% 15.12% 15.93% 17.05% 15.3% 15.67%
Earnings before Tax (EBT) 1 - 718 546 570 636 609 512 587 671.3 800.3 603 660.7
Net income 1 487 554 189 418 375 403 374 424.1 479.3 581.4 462.8 491.7
Net margin 10.64% 11.22% 4.02% 8.68% 7.78% 7.74% 8.04% 8.69% 9.46% 10.49% 9.42% 9.55%
EPS 2 - 1.210 0.4100 0.9100 0.8200 0.8800 0.8100 0.9125 1.031 1.254 0.9825 1.067
Dividend per Share 2 - - - 0.0600 0.0300 - - - - 0.2106 - -
Announcement Date 11/7/22 1/30/23 4/25/23 7/25/23 10/31/23 2/6/24 4/30/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 6,804 6,938 5,158 3,164 810
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) 2.157 x 1.946 x 1.403 x 0.7969 x 0.1904 x
Free Cash Flow 1 - 1,714 1,837 1,626 3,103
ROE (net income / shareholders' equity) - 19% 24.7% 24.2% 22.6%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - 15.70 18.50 23.50 28.10
Cash Flow per Share 2 - 4.590 4.840 5.970 6.870
Capex 1 310 387 409 415 426
Capex / Sales 1.69% 1.98% 2.03% 1.96% 1.91%
Announcement Date 1/30/23 2/6/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for GE HealthCare Technologies Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
78 USD
Average target price
92.74 USD
Spread / Average Target
+18.89%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.91% 35.61B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.01% 217B
DANAHER CORPORATION Stock Danaher Corporation
+11.01% 190B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+19.20% 143B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.79% 111B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.48% 64.59B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.95% 52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.16% 48.45B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-6.20% 38.03B
RESMED, INC. Stock ResMed, Inc.
+19.95% 30.31B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. GEHC Stock
  4. Financials GE HealthCare Technologies Inc.